Argus Cognitive launched Neurora, a tool that turns standard autism assessment data into objective, reviewable measurements for clinicians.

Founded in 2016, Argus Cognitive develops FDA-regulated software as medical devices that give healthcare professionals deeper insight from standard clinical workflows, so every decision starts from a stronger foundation. We combine expertise in artificial intelligence, medical device development, and clinical practice to build tools that meet the highest standards of safety, efficacy, and regulatory compliance, developed in close collaboration with healthcare professionals, researchers, and clinical institutions. Our work is grounded in a simple belief: advanced clinical analysis should be accessible without adding burden to the clinicians who depend on it. Our latest product, Neurora, is a clinical decision-support tool currently under FDA review that provides an objective behavioral data layer for observational autism assessments, giving diagnosticians deeper insight from the standard assessments they are already conducting. To schedule a demo or learn more, reach us at Neurora@ArgusCognitive.com.